Search clinical trials for: XEN®

Total 14639 results

Swiss Vision Network

Active, not recruiting

Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent

Glaucoma | Glaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma, Primary Open Angle
Medical University of Graz

Recruiting

Evaluation of Minimal Invasive Glaucoma Surgery

Glaucoma

Austria
AqueSys, Inc.

Completed

Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants

Primary Open Angle Glaucoma

Spain, Austria, Belgium, Italy, Germany, Poland, Switzerland, United Kingdom, Venezuela
Novo Nordisk A/S

Completed

A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects

Healthy | Growth Disorder

United States
Complejo Hospitalario Universitario de Albacete
University of Castilla-La Mancha

Recruiting

"Efficacy of Intermittent Enteral Nutrition Versus Continuous Administration in Intensive Care" (ENINCO)

Enteral Nutrition | Critical Care | Gastric Feeding Tube | Feeding Methods

Spain
Pila Pharma

Completed

A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in Patients With Diabetes Mellitus Type 2

Diabetes Mellitus, Type 2

Denmark
Saint-Joseph University

Completed

The Horizontal Ridge Augmentation Using Equine Xenograft and a Collagenated Porcine Cortical Lamina

Horizontal Ridge Deficiency

Lebanon
Xention Ltd

Completed

Fed-Fasted, Single and Multiple Ascending Dose Trial of XEN-D0103

Atrial Fibrillation

United Kingdom
Laboratoires Innothera
University Hospital, Grenoble; Floralis

Completed

Elastic Compression Stockings for Prevention of Post-thrombotic Syndrome (CELEST)

Deep Vein Thrombosis | Post-thrombotic Syndrome

France
Novo Nordisk A/S

Completed

A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Germany
Mingche Biotechnology CO., LTD

Not yet recruiting

Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma

Glaucoma
Zenith Epigenetics
Astellas Pharma Inc; Newsoara Biopharma Co., Ltd.

Recruiting

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer

United States, China
Chung Shan Medical University

Completed

Traditional Chinese Medicine Suan Tsao Jen Tang and Tian-Wang-Bu-Xin Dan in Patients With Primary Insomnia.

Insomnia
Price Vision Group

Terminated

Effect of Xen Implantation on the Aqueous Humor Proteome

Primary Open Angle Glaucoma

United States
Xention Ltd
Ario Pharma Ltd

Completed

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With Chronic Idiopathic Cough

Chronic Idiopathic Cough

United Kingdom, Ireland
Novo Nordisk A/S

Recruiting

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

Growth Hormone Disorder | Growth Hormone Deficiency in Children

United States, Japan, Israel, India, Austria, Slovenia, Belgium, Brazil, France, Germany, Sweden, Turkey, Ukraine
Xeno Biosciences

Not yet recruiting

A Phase 1b Study to Evaluate the Safety of XEN-101

Obesity
Allergan

Completed

Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma

Refractory Glaucoma

China
Xeno Biosciences

Completed

A Phase 1 Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of XEN-101

Healthy

Hungary
Allergan

Completed

Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)

Glaucoma

United States
Xention Ltd
Ario Pharma Ltd

Completed

A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Johns Hopkins University
New York University

Completed

Retrospective Review of Xen Gel Stent Implantation With Open vs. Closed Conjunctiva Approach

Glaucoma, Open-Angle

United States
Institut de l'oeil des Laurentides

Recruiting

A Prospective, Single Surgeon, Randomized Control Study Comparing ab Interno XEN Gel Microstent Implantation vs Closed Conjunctiva ab Externo Implantation Performed at the Slit Lamp for the Treatment of Uncontrolled Glaucoma

The Objective of the Study is to Prospectively Compare the Success Rate of ab Externo and Interno Implantation

Canada
Washington University School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

To Define the Role of GLP-1 for Improving Glucose Homeostasis in Humans Following Gastric Bypass Surgery

Roux-en-Y Gastric Bypass | Bariatric Surgery | Vertical Sleeve Gastrectomy | Gastric Banding | Bypass, Gastric

United States
Allergan

Completed

XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) (XEN GPS)

Glaucoma

United States
AqueSys, Inc.
Allergan

Completed

AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma

Glaucoma | Glaucoma, Open Angle

United States
Kochi University

Completed

Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of Life (KMS)

Hepatocellular Carcinoma | Chronic Liver Disease

Japan
Becton, Dickinson and Company

Completed

Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle

Diabetes

United States
Hospices Civils de Lyon

Completed

Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis

Patients Scheduled for Prostate Biopsy Because of Increased Serum PSA and/or Abnormal Digital Rectal Examination

France
Becton, Dickinson and Company

Completed

Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

Diabetes

United States
Sakarya University

Unknown

Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI

Myocardial Infarction | ST Elevation Myocardial Infarction

Turkey
Lumos Pharma

Active, not recruiting

Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) (OraGrowtH210)

Growth Hormone Deficiency

United States, Australia, Israel, New Zealand, Poland, Ukraine
Prism Eye Institute
Allergan

Recruiting

Safety and Efficacy of an Ab Interno Gelatin Stent (XEN63) With or Without Mitomycin C

Glaucoma, Open-Angle

Canada
GenMont Biotech Incorporation
Biomedical Development Corporation

Completed

the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis (PAR)

Probiotics | Perennial Allergic Rhinitis | Lactobacillus Paracasei GMNL-32 (eN-Lac®)

Taiwan
Pila Pharma
Biomapas

Completed

A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes

Diabetes Mellitus, Type 2 | Pharmacokinetics | Efficacy | Safety

Lithuania
Sanofi

Completed

Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Sanofi

Completed

Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients (GetGoal-Duo-2)

Type 2 Diabetes

United States, Canada, Chile, Czech Republic, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Mexico, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
Gilead Sciences
Merck Sharp & Dohme LLC

Active, not recruiting

Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV

HIV-1 Infection

United States
Sanofi

Completed

GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin (GETGOAL-X)

Diabetes Mellitus, Type 2

United States, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Spain, Sweden, Argentina, Denmark, Finland, Hungary, Norway, Colombia, Austria, Greece, Puerto Rico
Prism Eye Institute
Allergan

Completed

Ab Interno Gelatin Stent With Mitomycin C Using Targeted Supra-tenon's Placement

Glaucoma

Canada
Merck KGaA, Darmstadt, Germany

Completed

CONSORT Randomized Controlled Trial in Assisted Reproductive Technology

Infertility

Switzerland
C. R. Bard

Completed

Xen Matrix™ AB Surgical Graft in Ventral or Incisional Midline Hernias

Incisional Hernia

United States
Zhongshan Ophthalmic Center, Sun Yat-sen University
Allergan

Active, not recruiting

XEN45 in the Treatment of Chinese Patients With Primary Open-angle Glaucoma

Glaucoma | Glaucoma, Open-Angle | Surgery

China
Gilead Sciences

Active, not recruiting

Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection (PURPOSE 1)

Pre-Exposure Prophylaxis of HIV Infection

South Africa, Uganda
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Not yet recruiting

A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial (RENATO)

ANCA Associated Vasculitis | Rapidly Progressive Glomerulonephritis | Crescentic Glomerulonephritis
Claret Medical
Meditrial Europe Ltd.

Completed

Carotid Filtration During Endovascular Aortic Valve Implantation

Heart Diseases
Seno Medical Instruments Inc.

Suspended

Clinical Evaluation of Opto-Acoustic Image Quality With the Gen1B Duplex Probe in Breast Applications

Breast Cancer

United States
University Hospital, Bordeaux
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Relation Between Pregnenolone Endocannabinoids in Normal-weight and Obese Men (CannaPREG)

Obesity

France
Sansum Diabetes Research Institute
Novo Nordisk A/S

Completed

Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones. (SafrTravlT1D)

Diabetes Mellitus, Type 1

United States
Sanofi

Completed

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS) (GETGOAL-MONO)

Diabetes Mellitus, Type 2

Japan

Search clinical trials for: XEN®

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations